Both groups received the maximum tolerated dose of their medication: Tirzepatide group: 10 mg or 15 mg weekly (Zepbound) Semaglutide group: 1.7 mg or 2.4 mg weekly (Wegovy) Participants had a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition
Use the Peptide Reconstitution Calculator
Available from: Kornelius E, Huang JY, Lo SC, Huang CN, Yang YS
Personalized Peptide Therapy The future likely holds more personalized approaches where combinations of peptides are tailored to individual metabolic and health profiles, optimizing outcomes while minimizing side effects
Yagoda N, von Rechenberg M, Zaganjor E, Bauer AJ, Yang WS, Fridman DJ et al (2007) RASRAFMEK-dependent oxidative cell death involving voltage-dependent anion channels
For patients with diabetes, intensified glucose monitoring is crucial after discontinuation